The use of cholesterol-lowering medications and age-related macular degeneration

scientific article published on 01 March 2005

The use of cholesterol-lowering medications and age-related macular degeneration is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.OPHTHA.2004.10.027
P698PubMed publication ID15745779

P2093author name stringGerald McGwin
Aiyuan Xie
Cynthia Owsley
P433issue3
P921main subjectmacular degenerationQ27429789
P304page(s)488-494
P577publication date2005-03-01
P1433published inOphthalmologyQ7098109
P1476titleThe use of cholesterol-lowering medications and age-related macular degeneration
P478volume112

Reverse relations

cites work (P2860)
Q35593614A case control study of age related macular degeneration and use of statins.
Q37697907Age-related macular degeneration and protective effect of HMG Co-A reductase inhibitors (statins): results from the National Health and Nutrition Examination Survey 2005-2008.
Q34389315Age-related macular degeneration and risk of stroke
Q63951943Analogies entre processus athéromateux et dégénérescence maculaire liée à l’âge : rôles présumés des oxystérols
Q39685580Apolipoprotein B100 secretion by cultured ARPE-19 cells is modulated by alteration of cholesterol levels
Q35181364Association between statin use and uveitis: results from the Pacific Ocular Inflammation study
Q39742085Association between systemic arterial stiffness and age-related macular degeneration
Q37192985Can HMG Co-A reductase inhibitors ("statins") slow the progression of age-related macular degeneration? The age-related maculopathy statin study (ARMSS)
Q33507197Convergence of linkage, gene expression and association data demonstrates the influence of the RAR-related orphan receptor alpha (RORA) gene on neovascular AMD: a systems biology based approach
Q38083044Do statins have a role in the prevention of age-related macular degeneration?
Q28482265Dyslipidemia and eye diseases in the adult Chinese population: the Beijing eye study
Q93096280Effect of Statins, Metformin, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin II Receptor Blockers on Age-Related Macular Degeneration
Q28540642Elevated high-density lipoprotein cholesterol and age-related macular degeneration: the Alienor study
Q47128247Enhancing the efficacy of AREDS antioxidants in light-induced retinal degeneration
Q30239897Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors
Q33935415Identifying subtypes of patients with neovascular age-related macular degeneration by genotypic and cardiovascular risk characteristics.
Q42626090Influence of rosuvastatin on the NAD(P)H oxidase activity in the retina and electroretinographic response of spontaneously hypertensive rats.
Q35138088Lipids, lipoproteins, and age-related macular degeneration
Q43006634Mouse models may provide new insight into the relation between cholesterol and age related macular degeneration
Q35762030Plasma apolipoproteins and risk for age related maculopathy
Q36218190Plasma levels of complement proteins from the alternative pathway in patients with age-related macular degeneration are independent of Complement Factor H Tyr⁴⁰²His polymorphism.
Q37612307Role of statins in the development and progression of age-related macular degeneration.
Q36707183Statin use and ocular inflammatory disease risk
Q37456394Statin use and the incidence of advanced age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial.
Q36315753The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9
Q37780449The controversy over the association between statins use and progression of age-related macular degeneration: a mini review.
Q79765696[Epidemiology of age-related macular degeneration. Situation in Spain]

Search more.